Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
HCA trades against a final fair-value range of $496.77-$798.49, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
A prolonged period of elevated interest rates combined with flat commercial volumes and margin compression to 13% would severely stress HCA's free cash flowFree cash flowOperating cash flow minus capital expenditures. The cash a business generates after maintaining and growing its asset base — the closest accounting proxy for owner-economics., threatening the heavily leveraged capital structure and ending the share repurchase algorithm.
Government payers drastically compress Medicare/Medicaid rates to manage ballooning deficits, crushing margins.
Persistent clinical staff shortages force a permanent reliance on expensive contract labor, eroding operating margins below 14%.
Refinancing the massive $48.7B net debt load at significantly higher rates extinguishes the aggressive buyback program.
| Pozycja | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
|---|---|---|---|---|---|---|
| Przychody | — | $60.23B | $64.97B+7.9% | $70.60B+8.7% | $75.60B+7.1% | +5.8% |
| Zysk brutto | — | $23.18B | $25.58B | $28.68B | $31.37B | +7.9% |
| Zysk operacyjny | — | $9.05B | $9.63B | $10.55B | $11.97B | +7.2% |
| Zysk netto | — | $5.64B | $5.24B-7.1% | $5.76B+9.9% | $6.78B+17.7% | +4.7% |
| EPS (rozwodniony) | — | $19.15 | $18.97 | $22.00 | $28.33 | +10.3% |
| EBITDA | — | $13.29B | $12.72B | $13.90B | $15.60B | +4.1% |
| R&D | — | — | — | — | — | — |
| SG&A | $26.78B | $27.69B | $29.49B | $31.17B | — | +3.9% |
Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
